Are there etiology-specific risk factors for adverse outcomes in patients on Impella 5.5 support?Central MessagePerspective за авторством Jean-Luc A. Maigrot, BS, Lucy Thuita, MS, Michael Z.Y. Tong, MD, MBA, Edward G. Soltesz, MD, MPH, Nicholas G. Smedira, MD, MBA, Shinya Unai, MD, Randall C. Starling, MD, MPH, Andrew Higgins, MD, David Moros, MD, Eugene H. Blackstone, MD, Aaron J. Weiss, MD, PhD

Отримати повний текст